生物银行在个性化肿瘤调查和治疗方面的最新进展。

Q2 Medicine Medicine and Pharmacy Reports Pub Date : 2023-07-01 DOI:10.15386/mpr-2647
Liliana Policiuc, Andreea Nutu, Oana Zanoaga, Nikolay Mehterov, Cornelia Braicu, Ioana Berindan-Neagoe
{"title":"生物银行在个性化肿瘤调查和治疗方面的最新进展。","authors":"Liliana Policiuc,&nbsp;Andreea Nutu,&nbsp;Oana Zanoaga,&nbsp;Nikolay Mehterov,&nbsp;Cornelia Braicu,&nbsp;Ioana Berindan-Neagoe","doi":"10.15386/mpr-2647","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aim: </strong>A biobank is an organization that gathers, refines, preserves and provides access to biospecimens along with relevant clinical data that can be used in applied or clinical research. Biobanking is a critical component of the scientific foundation for personalized medicine; this implies the accessibility of high-quality human biospecimens, such as blood, tissue, and other body fluids, along with the patient clinical data that goes with them.</p><p><strong>Methods: </strong>This paper summarizes the function of biobanks in oncology and the requirements for biobank development in translational and clinical research.</p><p><strong>Results: </strong>Biobanks raise numerous ethical issues that government agencies address by enacting particular laws. To develop personalized medicine, biobanks are crucial, given that the availability of an extensive collection of patient samples with thoroughly annotated clinical and pathological data is an essential necessity. Also, data related to biobanking raises complex ethical, legal, and social issues, particularly concerning the protection of donor privacy and the appropriate use of collected samples. International standards have been developed to address these issues to ensure biobanking practices' quality, safety, and integrity.</p><p><strong>Conclusions: </strong>Biobanking is vital in advancing biomedical research, supporting clinical applications, and enhancing our understanding of human health and disease. Using real-world data and biobanking can accelerate medical research, support personalized medicine initiatives, and improve patient care.</p>","PeriodicalId":18438,"journal":{"name":"Medicine and Pharmacy Reports","volume":"96 3","pages":"235-245"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cc/dd/cm-96-235.PMC10419688.pdf","citationCount":"0","resultStr":"{\"title\":\"Current aspects in biobanking for personalized oncology investigations and treatments.\",\"authors\":\"Liliana Policiuc,&nbsp;Andreea Nutu,&nbsp;Oana Zanoaga,&nbsp;Nikolay Mehterov,&nbsp;Cornelia Braicu,&nbsp;Ioana Berindan-Neagoe\",\"doi\":\"10.15386/mpr-2647\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background/aim: </strong>A biobank is an organization that gathers, refines, preserves and provides access to biospecimens along with relevant clinical data that can be used in applied or clinical research. Biobanking is a critical component of the scientific foundation for personalized medicine; this implies the accessibility of high-quality human biospecimens, such as blood, tissue, and other body fluids, along with the patient clinical data that goes with them.</p><p><strong>Methods: </strong>This paper summarizes the function of biobanks in oncology and the requirements for biobank development in translational and clinical research.</p><p><strong>Results: </strong>Biobanks raise numerous ethical issues that government agencies address by enacting particular laws. To develop personalized medicine, biobanks are crucial, given that the availability of an extensive collection of patient samples with thoroughly annotated clinical and pathological data is an essential necessity. Also, data related to biobanking raises complex ethical, legal, and social issues, particularly concerning the protection of donor privacy and the appropriate use of collected samples. International standards have been developed to address these issues to ensure biobanking practices' quality, safety, and integrity.</p><p><strong>Conclusions: </strong>Biobanking is vital in advancing biomedical research, supporting clinical applications, and enhancing our understanding of human health and disease. Using real-world data and biobanking can accelerate medical research, support personalized medicine initiatives, and improve patient care.</p>\",\"PeriodicalId\":18438,\"journal\":{\"name\":\"Medicine and Pharmacy Reports\",\"volume\":\"96 3\",\"pages\":\"235-245\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cc/dd/cm-96-235.PMC10419688.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicine and Pharmacy Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15386/mpr-2647\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine and Pharmacy Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15386/mpr-2647","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

背景/目的:生物库是一个收集、提炼、保存和提供生物标本以及可用于应用或临床研究的相关临床数据的组织。生物银行是个性化医疗科学基础的重要组成部分;这意味着可以获得高质量的人体生物标本,如血液、组织和其他体液,以及与之相关的患者临床数据。方法:综述生物库在肿瘤学中的作用以及生物库在转化和临床研究中的发展要求。结果:生物银行引发了许多伦理问题,政府机构通过制定特定的法律来解决这些问题。为了开发个性化医疗,生物银行是至关重要的,因为广泛收集患者样本并充分注释临床和病理数据是必不可少的。此外,与生物银行相关的数据引发了复杂的伦理、法律和社会问题,特别是涉及到捐赠者隐私的保护和收集样本的适当使用。已经制定了国际标准来解决这些问题,以确保生物银行实践的质量、安全性和完整性。结论:生物银行在推进生物医学研究、支持临床应用和增强我们对人类健康和疾病的理解方面至关重要。使用真实世界的数据和生物银行可以加速医学研究,支持个性化医疗计划,并改善患者护理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Current aspects in biobanking for personalized oncology investigations and treatments.

Background/aim: A biobank is an organization that gathers, refines, preserves and provides access to biospecimens along with relevant clinical data that can be used in applied or clinical research. Biobanking is a critical component of the scientific foundation for personalized medicine; this implies the accessibility of high-quality human biospecimens, such as blood, tissue, and other body fluids, along with the patient clinical data that goes with them.

Methods: This paper summarizes the function of biobanks in oncology and the requirements for biobank development in translational and clinical research.

Results: Biobanks raise numerous ethical issues that government agencies address by enacting particular laws. To develop personalized medicine, biobanks are crucial, given that the availability of an extensive collection of patient samples with thoroughly annotated clinical and pathological data is an essential necessity. Also, data related to biobanking raises complex ethical, legal, and social issues, particularly concerning the protection of donor privacy and the appropriate use of collected samples. International standards have been developed to address these issues to ensure biobanking practices' quality, safety, and integrity.

Conclusions: Biobanking is vital in advancing biomedical research, supporting clinical applications, and enhancing our understanding of human health and disease. Using real-world data and biobanking can accelerate medical research, support personalized medicine initiatives, and improve patient care.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Medicine and Pharmacy Reports
Medicine and Pharmacy Reports Medicine-Medicine (all)
CiteScore
3.10
自引率
0.00%
发文量
63
期刊最新文献
5-Azacytidine treatment inhibits the development of lung cancer models via epigenetic reprogramming and activation of cellular pathways with anti-tumor activity. Artificial Intelligence and medical specialties: support or substitution? Clonal distribution and molecular characterization of Staphylococcus aureus isolated strains in Chania and Heraklion, Crete. Exploring anesthesia-related complications in pediatric neurosurgery: a comparative analysis of the sitting and park-bench positions. Genetic and clinical factors influencing CF-associated liver disease: the impact of SERPINA1 variants and CFTR genotypes in Romanian pediatric cystic fibrosis patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1